Chemours Co
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Chemours Co.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 10.50 $ to 27.90 $ · Last price: 14.40 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Specialty Chemicals
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Chemours Co CC | 2.3 | – | 10.4 | 15.4 | 3.0 | 0.5 | -14.1 |
| Linde plc LIN | 212.0 | 30.6 | 17.5 | 48.4 | 28.5 | 3.0 | -3.2 |
| Sherwin-Williams Co SHW | 77.7 | 31.5 | 19.5 | 49.0 | 14.2 | 2.1 | -7.5 |
| Ecolab Inc ECL | 76.7 | 37.6 | 21.6 | 44.2 | 16.9 | 2.2 | 3.5 |
| Air Products and Chemicals Inc APD | 64.1 | 30.2 | 48.8 | 32.1 | 23.6 | -0.5 | 1.1 |
| PPG Industries Inc PPG | 23.5 | 15.3 | 10.4 | 41.2 | 13.7 | 0.2 | -0.6 |
| International Flavors & Fragrances Inc. IFF | 21.7 | 26.8 | 59.0 | 36.6 | 10.1 | -5.2 | 37.3 |
| LyondellBasell Industries NV LYB | 21.1 | – | 16.7 | 12.9 | 3.5 | -25.2 | 27.6 |
| Sociedad Quimica y Minera de Chile SA SQM | 20.5 | 25.3 | 8.6 | 42.2 | 41.1 | 0.9 | 60.5 |
| Median of companies shown | 23.5 | 30.2 | 17.5 | 41.2 | 14.2 | 0.5 | 1.1 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 5,400 | 96 | 7 | 0.04 | 594 | 100 | 6,060 |
| 2017 | 6,183 | 1,072 | 746 | 3.91 | 639 | 860 | 7,293 |
| 2018 | 6,638 | 1,232 | 995 | 5.45 | 1,140 | 1,014 | 7,362 |
| 2019 | 5,526 | 447 | -52 | -0.32 | 650 | 689 | 7,258 |
| 2020 | 4,969 | 448 | 219 | 1.32 | 807 | 813 | 7,082 |
| 2021 | 6,345 | 674 | 608 | 3.60 | 820 | 1,081 | 7,550 |
| 2022 | 6,831 | 786 | 578 | 3.65 | 754 | 1,107 | 7,640 |
| 2023 | 6,078 | -123 | -238 | -1.60 | 556 | 737 | 8,251 |
| 2024 | 5,782 | 443 | 86 | 0.57 | -633 | 604 | 7,515 |
| 2025 | 5,808 | -5 | -386 | -2.56 | 264 | 250 | 7,382 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.05 | – | 1,359 | -0.70 | -0.80 | 138 | 29 |
| 2025: Q1 | -0.03 | -107.40 | 1,368 | 0.40 | -0.30 | -112 | -196 |
| 2025: Q2 | -2.54 | -734.50 | 1,615 | 3.90 | -23.60 | 93 | 50 |
| 2025: Q3 | 0.40 | – | 1,495 | -0.40 | 4.00 | 146 | 105 |
| 2025: Q4 | -0.41 | – | 1,330 | -2.10 | -4.60 | 137 | 92 |
| 2026: Q1 | -0.19 | – | 1,381 | 1.00 | -2.10 | -44 | -93 |
| 2026: Q2 | -1.81 | 28.70 | 1,591 | -1.50 | -17.20 | 158 | 114 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.01 | 0.76 – 1.20 | 5,922 | 6.2% | 9 |
| 12/31/2027 | 1.93 | 1.76 – 2.25 | 6,211 | 91.1% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 6.5% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $125.0M |
|---|---|
| Market cap | $2.29B |
| Free cash flow in year ten | $235.5M |
| Terminal value as a share of market value | 54.1% |
For comparison: over the past five years free cash flow shrank by 37.6% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -5.3%
- More than 10% revenue growth is expected for the coming year 5.6%
- Share count grows by less than 3% a year -1.7%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 1.3%
- Gross margin at 40% or higher and without meaningful erosion 15.5%
- Goodwill from acquisitions does not grow faster than revenue 0.6%
- Net debt below twice EBITDA 11.8 x EBITDA
- Operating cash flow covers the profits of the last three years 725 m
- Return on capital at 15% or higher, or up versus two years ago -0.1%
- Insiders hold at least 10% or are net buyers 0.4%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
0/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 0.8%
- Exp. sales growth 3Y > 5% 3.4%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% 3.4%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 8
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% -191.1%
- ROCE > 15% -0.1%
- Expected return > 10% 5.7%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Will David | Chief Accounting Officer | Other | 2,426 | 15.24 | 36,972 |
| Aug 12, 2026 | Familiar Calderon Gerardo | See Remarks | Buy | 1,935 | 15.53 | 30,051 |
| Aug 11, 2026 | Dignam Denise | Chief Executive Officer | Buy | 3,378 | 14.95 | 50,501 |
| Aug 7, 2026 | Cowan Alister | Director | Buy | 13,000 | 15.62 | 203,060 |
| Aug 7, 2026 | Foley Michael Robert | See Remarks | Buy | 1,934 | 15.51 | 29,996 |
| Aug 7, 2026 | Martinko Joseph T. | See Remarks | Buy | 1,940 | 15.47 | 30,012 |
| Aug 7, 2026 | Cranston Mary B | Director | Buy | 6,000 | 15.83 | 94,950 |
| Aug 6, 2026 | Hostetter Shane | Chief Financial Officer | Buy | 3,350 | 14.94 | 50,049 |
| Aug 6, 2026 | Hostetter Shane | Chief Financial Officer | Other | 3,087 | 15.11 | 46,645 |
| Aug 1, 2026 | Martinko Joseph T. | See Remarks | Other | 663 | 16.61 | 11,012 |
The company
About the Company
- CEO Insider Trades (12 Mo.)
- buying own stock
- Employees
- 5,700
- Headquarters
- Wilmington, DE
- Address
- 1007 Market Street, 19801 Wilmington, United States
- Phone
- 302 773 1000
- Website
- chemours.com
- IPO Date
- 07/01/2015
- ISIN
- US1638511089
Management
| Name | Title | Birth Year |
|---|---|---|
| Denise M. Dignam | President, CEO & Director | 1966 |
| Shane W. Hostetter CPA | Senior VP & CFO | 1981 |
| Kristine M. Wellman | Senior VP, General Counsel & Company Secretary | 1970 |
| Gerardo Familiar Calderon | President of Advanced Performance Materials | 1977 |
| Joseph T. Martinko | President of Thermal & Specialized Solutions | 1969 |
| David A. Will | Controller & Chief Accounting Officer | 1985 |
| Brandon Ontjes | Vice President of Investor Relations | – |
| Matthew J. Conti | Chief Human Resources Officer | – |
| Aditya Beri | Interim President of Titanium Technologies & Chemical Solutions Business | – |
| Diane Iuliano Picho | Chief Enterprise Enablement Officer | 1962 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 09/10/2026 Chemours Co (CC): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 09/09/2026 Chemours Co (CC): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 08/04/2026 Chemours Co (CC): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.